This document summarizes a presentation on testicular failure in humans. It discusses the current management and future perspectives on this condition. Some key points include:
- Spermatogenic failure is a challenging condition affecting 1% of men and is usually irreversible. About 40-50% of men with this condition still have residual spermatogenesis that can be retrieved.
- Diagnostic tests are not always accurate in predicting if sperm can be found, but a genetic assessment of the Y chromosome can provide helpful information.
- Different management approaches are used at Androfert clinic, including counseling, identifying candidates that may benefit from interventions before sperm retrieval, selecting the best sperm retrieval method, and using advanced lab techniques.
(Rocky) Jaipur Call Girl - 09521753030 Escorts Service 50% Off with Cash ON D...
Testicular Failure in Humans: Current Management and Future Perspectives
1. V ISABR 2014
Testicular Failure in Humans
Current Management and
Future Perspectives
Sandro C. Esteves, MD., PhD.
Medical Director, ANDROFERT
Campinas, Brazil
2. Learning objectives
At the completion of this talk participants should
be able to:
• Overview the technical aspects of ICSI as
carried out in humans
• Understand why spermatogenic failure (SF) is
one of the most challenging condition in
human reproduction
• Learn how we manage men with SF seeking
fertility at Androfert
ANDROFERT
androfert.com.br
ANDROFERT
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 2
2014 OCTOBER
3. Testicular Failure in Humans
Current Management and Future
Perspectives
http://www.androfert.com.br/review
ANDROFERT
androfert.com.br
ANDROFERT
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 3
2014 OCTOBER
5. Spermatogenic failure is the worst
prognostic condition in male infertility
§ Up to 1% of all men; 10-15% of infertile
males
§ Irreversible condition; often termed as
“sterile”
§ Semen analysis reveals “Azoospermia”
Should be confirmed in multiple specimens after
examination of pelleted semen
Esteves & Agarwal. Sperm Retrieval Techniques; In: Gardner et al.
Human Assisted Reproductive Technology. Cambridge, pp. 41-53, 2011
ANDROFERT
androfert.com.br
ANDROFERT
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 5
2014 OCTOBER
6. Spermatogenic failure is an
irreversible condition
Congenital
Testicular dysgenesis/cryptorchidism
Genetic abnormalities (Klinefelter syndrome, Yq microdeletions, etc.)
Acquired
Testicular torsion; Trauma
Post-inflammatory (eg. Mumps orchitis)
Exogenous factors (eg. Cytotoxic drugs, irradiation)
Testicular cancer
Systemic diseases (eg. Liver cirrhosis, renal failure)
Idiopathic (Unknown etiology)
Esteves et al. Clinics 2011; 66: 691-700
ANDROFERT
androfert.com.br
ANDROFERT
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 6
2014 OCTOBER
7. Goals of semen analysis are to reduce
analytical error and enhance precision
Examination of pelleted
semen
Differentiation between ‘true’
azoospermia (lack of any
sperm) and cryptozoospermia
(very few sperm)
Minimum 2-3 analyses
Transient azoospermia due to
medical conditions and
biological variability
Centrifugation at 3,000g
for 15 minutes
Esteves et al Int Braz J Urol 2014; 40: 443-53
ANDROFERT
androfert.com.br
ANDROFERT
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 7
2014 OCTOBER
Supernatant is
discharged
Pellet is meticulously
examined
8. Prognosis and management differentially
affected by type of azoospermia
Azoospermia
Obstructive
Non-obstructive
Types
Spermatogenic
failure
Hypo-hypo
Clinical Picture
NL testes
NL FSH, LH, TT
Mechanical blockage
FSH/LH: ñ or nl
TT: low or nL
Testes: small or nl
FSH/LH <1.2 mUI/mL,
Low TT, small testis,
poor virilization
Spermatogenesis
Normal
ANDROFERT
androfert.com.br
ANDROFERT
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 8
2014 OCTOBER
Disrupted
9. Diagnostic parameters provide >90%
prediction of whether azoospermia is due
to spermatogenic failure
Medical history
Cryptorchidism, testicular trauma, torsion, infection, radio-/
chemotherapy, congenital abnormalities, systemic diseases
Physical examination
Small testes (<15 cc; long axis <4.6 cm)
Flat epididymis, palpable vas
Endocrine profile
Elevated FSH levels (>7.6 mIU/ml in 90% men)
Low testosterone levels (<300 ng/dl in up to 50%)
ANDROFERT
androfert.com.br
ANDROFERT
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 9
2014 OCTOBER
Esteves et al Clinics 2011
10. Isolated diagnostic biopsy rarely indicated
provide no definitive proof of whether sperm will be
found; may jeopardize future retrieval attempts
Differential diagnosis
with obstructive
azoospermia
Work-up in SF associated to
maturation arrest is
unrevealing
Wet examination and
cryopreservation if
sperm found
Hypospermatogenesis
Maturation arrest
Sertoli cell-only
Verza Jr & Esteves, Atlas of Human Reproduction SBRH 2013
ANDROFERT
androfert.com.br
ANDROFERT
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 10
2014 OCTOBER
11. Obstructive azoospermia is a favorable
prognostic condition in male infertility
Management options include
reconstructive surgery and ART
Sperm retrieval
highly successful
regardless of cause
of obstruction and
method of retrieval
ANDROFERT
androfert.com.br
ANDROFERT
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 11
2014 OCTOBER
OBSTRUCTIVE
AZOOSPERMIA
OA (N=146)
100% 96.6% 96.3%
CBAVD Vasectomy Post-‐infection
Esteves et al. J Urol. 2013;189: 232-7
12. ICSI outcome in obstructive azoospermia
comparable with fertile donors
Obstructive azoospermia (N=146)
Donor sperm (N=40)
64
61
47
34
61
66
50
38
2PN
Fertilization
(%)
High quality
embryos (%)
Clinical
pregnancy (%)
Live birth (%)
ANDROFERT
androfert.com.br
ANDROFERT
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 12
2014 OCTOBER
p=NS
Esteves et al. Asian J Androl 2014; 16: 602-6
13. Hypogonadotropic hypogonadism favorable
prognosis and simple management
Series of men with adult-onset hypo-hypo
Recombinant hCG (Ovitrelle 250 mcg); SC, qw
Baseline
Posttreatment
Esteves & Papanikolaou Fertil Steril 2011; 96 (Suppl.): S230
ANDROFERT
androfert.com.br
ANDROFERT
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 13
2014 OCTOBER
14. Frequency of azoospermia among 2,383
patients attending an Infertility Clinic
3%
36%
Esteves et al. Clinics 2011; 66: 691-700.
ANDROFERT
androfert.com.br
Azoospermia
35%
ANDROFERT
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 14
2014 OCTOBER
61%
Hypo-hypo
OA
SF
15. About 40-50% of men with SF have residual
spermatogenesis within the testis
§ Not enough for sperm to
appear in ejaculate
§ 600-800 seminiferous tubules
§ Goal is identify site of
production and retrieve
sperm for ICSI
§ Geographic location
unpredictable
Esteves et al. Sperm Retrieval Techniques. Int Braz J Urol 2011; 37: 570-83
ANDROFERT
androfert.com.br
ANDROFERT
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 15
2014 OCTOBER
16. Challenges faced by health professionals
providing care for men with SF are manifold
§ Counseling about the chances of finding
testicular sperm
§ Usefulness of any medical intervention
before sperm retrieval
§ Which sperm retrieval method to apply
§ Reproductive potential of retrieved
gametes in ICSI treatment
§ Health of offspring
ANDROFERT
androfert.com.br
ANDROFERT
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 16
2014 OCTOBER
17. Clinical management of men with
spermatogenic failure at Androfert
1. Counsel
about the
chances of
finding
sperm for
ICSI
2. Select who
could benefit
from
interventions
before sperm
retrieval
3. Select
the best
SR method
4. Use of state-of-
art lab
techniques to
handle the
retrieved
gametes
ANDROFERT
androfert.com.br
ANDROFERT
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 17
2014 OCTOBER
18. Clinical management of men with
spermatogenic failure at Androfert
ANDROFERT
androfert.com.br
1. Counsel
about the
chances of
finding
sperm for
ICSI
2. Select who
could benefit
interventions
before sperm
retrieval
ANDROFERT
from
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 18
2014 OCTOBER
3. Select
the best
SR method
4. Use of state-of-
art lab
techniques to
handle the
retrieved
gametes
19. elec%ng
candidates
for
SR
Can
biomarkers
predict
SR
success?
Diagnostic markers reflect global testicular
function but not the presence of a site of
active spermatogenesis
FSH levels
Testosterone
levels
Testicular
volume
ANDROFERT
androfert.com.br
ANDROFERT
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 19
2014 OCTOBER
Verza Jr & Esteves. Fertil Steril 2011; 96 (Suppl.): S53
20. Biopsy helpful for counseling
but does not provide definitive proof of whether sperm
will be found; may jeopardize future retrieval attempts
Presence of sperm within the
100%
testicle (N=357)
40.3%
19.5%
Hypospermatogenesis
Maturation Arrest
Seroli-cell only
Esteves & Agarwal. Asian J Androl 2014; 16: 642
Testicular
histopathology
ANDROFERT
androfert.com.br
ANDROFERT
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 20
2014 OCTOBER
21. Etiology cannot determine whether or not
sperm will be found within the testis
Esteves et al Fertil Steril 2010; Raman & Schlegel J Urol 2003;
Hopps et al. Hum Reprod 2003; Damani et al JCO 2002
Etiology category
Success in finding
sperm
Cryptorchidism
52-74%
Post-infection
67%
Torsion
>50%
Post-chemotherapy/RT
25-75%
Genetic
25-70%
Idiopathic
50-60%
ANDROFERT
androfert.com.br
ANDROFERT
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 21
2014 OCTOBER
22. Genetic assessment of AZF region within the
Y chromosome helpful to determine the
chances of finding testicular sperm
Microdeletions
within AZF
region found in
up to 15% of
men with SF
Hamada et al. Clinics 2013; 68 (Suppl 1): 39-60; Krausz et al. Andrologia 2014; 2: 5-19
ANDROFERT
androfert.com.br
ANDROFERT
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 22
2014 OCTOBER
23. Multiplex-PCR molecular diagnosis of
YCMD
#4
Normal male
#5
AZFb microdeletion
#6
AZFc microdeletion
Krausz et al. Andrologia 2014; 2: 5-19
ANDROFERT
androfert.com.br
ANDROFERT
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 23
2014 OCTOBER
24. Complete AZFa, AZFb or AZFa+b
microdeletions unfavorable prognosis;
SR not recommended
✕ ✕ ✕
nil
nil
50-70%
Hamada et al. 2013; Krausz et al. 2014; Esteves et al. 2013
ANDROFERT
androfert.com.br
ANDROFERT
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 24
2014 OCTOBER
Chances of
finding sperm
within the
testis
25. 1. Counseling about chances of finding
sperm and who are candidates for SR
Key messages
§ Diagnostic parameters not accurate to
determine if residual spermatogenesis exists
§ YCMD screening mandatory to “deselect” men
with AZFa-b deletions from undergoing SR
§ Male offspring of fathers with AZFc
microdeletions will inherit the Yq deletion
(infertility)
ANDROFERT
androfert.com.br
ANDROFERT
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 25
2014 OCTOBER
26. Clinical management of men with
spermatogenic failure at Androfert
2. Identify who may
benefit from
interventions
before sperm
retrieval
ANDROFERT
androfert.com.br
ANDROFERT
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 26
2014 OCTOBER
27. Rationale for medication
Paradoxically weak stimulation of Leydig and
Sertoli cells by endogenous gonadotropins
- Due to high baseline FSH and LH levels the
relative amplitudes are low
Hypogonadism (TT<300 ng/dl) in up to 50%
men with SF
- High ITT levels essential for regulating
spermatogenesis in combination with Sertoli
cell stimulation with FSH
Shiraishi et al Hum Reprod 2012; 27: 331-9; Sussman et al Urol Clin N Am 2008; 35: 147-55
ANDROFERT
androfert.com.br
ANDROFERT
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 27
2014 OCTOBER
28. ANDROFERT
androfert.com.br
Study Study design Study group Medication Findings
Pavlovich
Case series 43 men with
et al. 2001 T/E ratio <10 Testolactone No effect
Hussein et
Prospective
al. 2005
cohort
42 men with
favorable
hystology
ANDROFERT
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 28
2014 OCTOBER
Clomiphene
Sperm found in SA in 64.3%; All men
who remained azoospermic had
success at SR
Selman et
al. 2006
Prospective
cohort
49 men with
maturation
arrest
rec-hFSH and hCG No return of sperm in ejaculate;
posttreatment SRR were 21.4%
Ramasamy
et al. 2009 Case series
56 men with
nonmosaic
Klinefelter
Testolactone or anastrozole,
alone or combined with hCG SRR increased by 1.4-fold
Reifsnyder
et al. 2012
Retrospective
cohort
307 men with
hypogonadis
m
Aromatase inhibitors, hCG or
Clomiphene, alone or
combined
No effect
Shiraishi et
al. 2012
Prospective
cohort
28 men with
idiopathic SF
hCG alone or combined with
rec-hFSH
SR success in 21% of the treated men
vs. none in untreated men
Hussein et
al. 2013
Prospective
cohort
612
unselected
men
Clomiphene alone or
combined with hCG or hMG
Sperm found in SA in 10.9% of treated
males; SRR higher in men who
remained azoospermic and treated
(57.0 vs. 33.6%, p<0.001)
!
There may be a role for medical treatment
but more studies are needed
29. Mechanism of action unclear but may be
related to high ITT that stimulate residual
spermatogenic areas
ITT (ng/dl)
273
1348
Before
After
ITT levels increased after
hCG-based therapy
Spermatogonial DNA
synthesis increased
Shinjo E et al Andrology 2013; 1: 929-35; Shiraishi et al Hum Reprod 2012; 27: 331-9.
ANDROFERT
androfert.com.br
ANDROFERT
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 29
2014 OCTOBER
PCNA expression
30. Medication algorithm at Androfert
Testosterone and estradiol
levels
<300
ng/dL
(10.4 nmol/L)
Hypogonadism
category
Pure
Treatment aimed at
boosting endogenous
T production
Aromatas
e inhibitor
(anastrozole 1mg
orally qid)
Rec-hCG
(250 mcg SC qw);
rec-FSH added
(75 IU SC biw) if FSH
levels <1.5 mIU/ml
ANDROFERT
androfert.com.br
T/E ratio
<10
T/E ratio
>10 (nl)
ANDROFERT
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 30
2014 OCTOBER
Aromatase
hyperactivity
31. Varicocele associated with impaired
spermatogenesis
Proposed mechanisms
include heat-mediated
stress and ischemia
Spermatogonia B,
pachytene spermatocytes
and early spermatids
highly vulnerable to heat
stress
Agarwal, Hamada & Esteves Nature Rev Urol 2012; 9: 678-90
ANDROFERT
androfert.com.br
ANDROFERT
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 31
2014 OCTOBER
32. Rationale for varicocele repair
Catch-up testicular growth among
adolescents following varicocele
repair
Improvement in sperm parameters
after varicocele repair
Abnormally-low T restored to normal
levels in some men after varicocele
repair
Wang et al Fertil Steril 1991; 55: 152-5; Su et al J Urol 1995; 154: 1752-5;
Çayan et al J Urol 2002; 168: 929731-4; Hamada et al Nat Rev Urol 2013; 10: 26-37
ANDROFERT
androfert.com.br
ANDROFERT
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 32
2014 OCTOBER
33. Among 233 men with SF and clinical
varicocele, about 1/3 had motile sperm in
ANDROFERT
androfert.com.br
postoperative ejaculate
ANDROFERT
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 33
2014 OCTOBER
Weedin et al J Urol 2010; 183: 2309-15
34. Varicocele success depend on the presence
of spermatogenesis in histopathology
Maturation arrest and hypospermatogenesis
favorable prognosis
ANDROFERT
androfert.com.br
ANDROFERT
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 34
2014 OCTOBER
Weedin et al J Urol 2010; 183: 2309-15
35. Although 2/3 remain azoospermic after
varicocele repair, sperm retrieval success
increased in treated individuals
§ Inci 2009
OR: 2.63; 95% CI: 1.05-6.60; p=0.03)
§ Haydardedeoglu 2010
Inci et al J Urol 2009; 182: 1500-5;
Haydardedeoglu et al Urology 2010; 75:83-6
SR success (%)
p<0.01
ANDROFERT
androfert.com.br
ANDROFERT
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 35
2014 OCTOBER
53
30
Treated
(N=66)
Untreated
(N=30)
61
38
Treated
(N=31)
Untreated
(N=65)
36. 2. Identify who may benefit from
interventions before sperm retrieval
Key messages
ANDROFERT
androfert.com.br
§ Medication to boost endogenous T
production seems beneficial to improve
spermatogenesis, particularly in men with
low T levels and low T/E ratio
§ Repair of clinical varicocele should be
considered in ICSI candidates before SR
ANDROFERT
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 36
2014 OCTOBER
37. Clinical management of men with
spermatogenic failure at Androfert
1. Counsel
about the
chances of
finding
sperm for
ICSI
2. Select who
could benefit
from
interventions
before sperm
retrieval
3. Select
the best
sperm
retrieval
method
4. Use of state-of-
art lab
techniques to
handle the
retrieved
gametes
ANDROFERT
androfert.com.br
ANDROFERT
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 37
2014 OCTOBER
38. Methods for sperm retrieval in SF include
percutaneous and open surgical procedures
Technique
Acronym
Success
Testicular Sperm
Aspiration
TESA
15-50%
Testicular Sperm
Extraction
TESE
20-60%
Microdissection
Testicular Sperm
Extraction
Micro-
TESE
40-67%
Esteves et al Int Braz J Urol 2013; 37: 570-83; Deruyver et al Andrology 2014; 2: 20-4
ANDROFERT
androfert.com.br
ANDROFERT
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 38
2014 OCTOBER
39. Microsurgical method yields higher success
regardless of histopathology findings
45%
Sperm Retrieval Success Rates
Micro-TESE
single-biopsy TESE
93%
64%
64%
25% 20%
9% 6%
Overall
Hypospermatogenesis
Maturation Arrest
Sertoli-cell Only
Controlled series (N=60)
Histology categories
pairwise comparisons:
p<0.0001
Method
P=0.0005
ANDROFERT
androfert.com.br
ANDROFERT
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 39
2014 OCTOBER
Verza Jr & Esteves. Fertil Steril 2011; 96 (Suppl.): S53
40. Esteves SC Int Braz J Urol 2013; 39(3):440
http://androfert.com.br/videos
41. 3. Selecting the best sperm retrieval
method
Key message
Microsurgical
testicular sperm
extraction is key
in SF
ANDROFERT
androfert.com.br
ANDROFERT
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 41
2014 OCTOBER
42. Clinical management of men with
spermatogenic failure at Androfert
1. Counsel
about the
chances of
finding
sperm for
ICSI
2. Select who
could benefit
from
interventions
before sperm
retrieval
3. Select
the best
SR method
4. Use of state-of-
art lab
techniques to
handle the
retrieved
gametes
ANDROFERT
androfert.com.br
ANDROFERT
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 42
2014 OCTOBER
43. • Optimize sperm retrieval
• Mechanical mincing
• Enzymatic tissue digestion
• Avoid iatrogenic damage
ANDROFERT
androfert.com.br
ANDROFERT
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 43
2014 OCTOBER
44. Tissue removed (mg)
Large Single-
Biopsy TESE
Micro-
TESE
P-value
65 ± 25
8.9 ± 2.5
<0.01
Optimizing sperm
retrieval
Conven6onal
TESE
Micro-‐TESE
Fragment
weight
Fragment
weight
Verza Jr & Esteves Fertil Steril 2011;
Esteves & Varghese J Reprod Sci 2013
ANDROFERT
androfert.com.br
ANDROFERT
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 44
2014 OCTOBER
45. Morphometric Evaluation of
Seminiferous Tubules
ANDROFERT
androfert.com.br
420
400
380
360
340
320
300
280
260
240
220
200
180
ANDROFERT
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 45
2014 OCTOBER
Median
25%-75%
5%-95%
Raw Data
yes No
Presence of Sperm
160
Max. Tubule Diameter
Verza Jr S, Esteves SC. Fertil Steril 2012; 98: S242
N=54; Tubule Diameter: KW-H (1;54) = 25.2; P<0.001
47. Clean Room Technology & ICSI Results
2,315 patients; 14,660 embryos
On average, one top-quality additional
embryo for transfer or cryopreservation
ANDROFERT
androfert.com.br
ANDROFERT
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 47
2014 OCTOBER
Esteves & Bento. Reprod Biomed Online 2013; 26: 9-21
48. 4. Using state-of-art lab techniques to
handle gametes of men with SF
Key messages
§ Increase the chances of finding sperm from
extracted testicular tissue
§ Avoid iatrogenic damage to the already
compromised gametes
§ Optimize ICSI outcome
ANDROFERT
androfert.com.br
ANDROFERT
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 48
2014 OCTOBER
49. What we have achieved after doing this
herculeous effort
ANDROFERT
androfert.com.br
41.4
Spermatogenic failure (N=365)
ANDROFERT
47.0
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 49
2014 OCTOBER
43.3
20.0
Sperm
retrieval
success (%)
2PN
fertilization
after ICSI (%)
High quality
embryo
generated by
ICSI (%)
Live birth per
treatment
cycle (%)
Esteves et al Asian J Androl 2014; 16: 602-6
50. Why we do all that
ANDROFERT
androfert.com.br
ANDROFERT
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 50
2014 OCTOBER
51. What about the health of resulting
ANDROFERT
androfert.com.br
ANDROFERT
offspring
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 51
2014 OCTOBER
Esteves et al Asian J Androl 2014; 16: 602-6
52. NeoHneaatltahl
oOf uotffcsopmrineg
o rfe
Baassbuierisn
gBorn
but a call for continuous monitoring needed due
to limited data and lack of long-term follow-up
Region
N
Outcome
analyzed
Main findings
Palermo et al.
1999
USA
22
Congenital
abnormalities
No difference with obstructive
azoospermia 4.5% vs 1.3%
Vernaeve et al.
2005
Belgium
61
Perinatal data;
Congenital
abnormalities
Lower gestational age (singletons);
Increased frequency of premature twins;
No difference with OA (4% vs 3%)
Fedder et al
2007
Denmark
76
Congenital
abnormalities
No difference with other infertility
categories (0% vs 4.0%)
Belva et al.;
2011
Belgium
193
Perinatal data;
Congenital
abnormalities
Similar perinatal outcomes; no
difference 4.2% SF vs 5.2% OA (ns)
Esteves & Agarwal. Clinics 2013; 68 (Suppl.1): 141-50
ANDROFERT
androfert.com.br
ANDROFERT
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 52
2014 OCTOBER
53. What the future holds for men with
ANDROFERT
androfert.com.br
spermatogenic failure…
ANDROFERT
ANDROLOGY AND HUMAN REPRODUCTION CLINIC - REFERRAL CENTER FOR MALE REPRODUCTION
S ESTEVES, 53
2014 OCTOBER